Cadence Pharmaceuticals Inc., of San Diego, named Scott Byrd senior vice president and chief commercial officer

It also promoted Jeff Devlin to chief operating officer and Peter Collins to senior vice president of business development...FoldRx Pharmaceuticals Inc., of Cambridge, Mass., named William E. Aliski senior vice president and chief commercial officer

subsidiary, which raises awareness of subclinical zinc deficiency and chronic copper toxicity...InfuSystem, of Madison Heights, Mich., hired Bryan Russo as chief commercial officer

Sinobiomed Inc., of Shanghai, China, made these appointments: Anchie Kuo, president and CEO...Spectrum Pharmaceuticals Inc., of Irvine, Calif., named Andrew Sandler chief medical officer, Michael Adam senior vice president of pharmaceutical operations, and Amar Singh chief commercial officer

Amylin Pharmaceuticals Inc., of San Diego, appointed Vincent P. Mihalik senior vice president of sales and marketing and chief commercial officer...Anecova SA, of Geneva, named Barry W. Wilson, Patrick Aebischer and Jeffrey B. Jump to its board

InCyte Corp., of Wilmington, Del., appointed Patricia S. Andrews executive vice president and chief commercial officer...and Faith Pomeroy-Ward as executive director of investor relations and corporate communications

Enobia Pharma, of Montreal, named Julie Anne Smith vice president and chief commercial officer and appointed Jayant Aphale vice president of manufacturing and process sciences...It formed its scientific advisory board with the appointments of Dennis Brown, Xandra Breakefield and Richard L. Edelson, and also appointed Johan Skog director of genetics research

MediGene AG, of Martinsried, Germany, said Thomas Strüngmann and Mathias Albert Boehringer were elected as new supervisory board members...Synta Pharmaceuticals Corp., of Lexington, Mass., named Michael P. Bailey as senior vice president and chief commercial officer

Synta Pharmaceuticals Corp., of Lexington, Mass., appointed Michael P. Bailey senior vice president and chief commercial officer, effective Aug. 4...and Jay Rheingold vice president of chemistry, manufacturing and controls

Exiqon, of Vedbaek, Denmark, appointed Cynthia K. French chief scientific officer and Erik Holmlin chief commercial officer...Ikonysis, of New Haven, Conn., named Louise Mawhinney senior vice president and chief financial officer

Neuromed Pharmaceuticals, of Conshohocken, Pa., promoted Sean Cunliffe to chief commercial officer...Oragenics Inc., of Alachua, Fla., named Marc Siegel and Kevin Sills to its board

MacroGenics Inc., of Rockville, Md., appointed Jean-Christophe Tellier executive vice president and chief commercial officer and James Karrels vice president and chief financial officer

plc, of Dublin, Ireland, named Jonas Frick and Giles Kerr nonexecutive directors...Micromet Inc., of Bethesda, Md., appointed Mark Reisenauer senior vice president and chief commercial officer

Chromatin also appointed Caroline Kovac and John Hamer to its board of directors...Peplin Ltd., of Emeryville, Calif., appointed George W. Mahaffey chief commercial officer and vice president of sales and marketing

Joseph Schachle to executive vice president and chief of commercial operations

Viral Genetics Inc., of Azusa, Calif., appointed Marcus Altfeld and Todd Allen to its scientific advisory board...ViroPharma Inc., of Exton, Pa., added Daniel Soland as vice president and chief commercial officer

Halozyme Therapeutics Inc., of San Diego, appointed Connie Matsuie to its board and Robert Little vice president and chief commercial officer

Halozyme Therapeutics Inc., of San Diego, appointed Connie Matsuie to its board and Robert Little vice president and chief commercial officer...It also established a business advisory board and appointed three former company directors to it: William Milligan, Andrew Saxton and Christopher Neuman

and Jeff Silverman vice president, operations integration and new technology development...John Weidenbruch as general counsel and assistant corporate secretary